📊 IVPR Key Takeaways
Is Inspire Veterinary Partners, Inc.. (IVPR) a Good Investment?
IVPR demonstrates severe operational distress with massive losses, negative margins, and deteriorating cash flow that exceed revenues by 30%. The company faces acute solvency risk with a current ratio of 0.39x and only $576K in cash against $11.8M in long-term debt, making continued operations questionable without immediate capital infusion.
Inspire Veterinary Partners shows severely impaired fundamentals: revenue is essentially flat while operating and net losses remain extremely large relative to sales, with a -53.8% operating margin and -65.2% net margin. The balance sheet and cash flow profile are also stressed, with only $576.25K of cash, a 0.39x current ratio, negative free cash flow, and debt/equity of 2.82x. Unless management can materially improve clinic-level profitability and liquidity, the current financial profile suggests elevated solvency and dilution risk rather than durable business quality.
Why Buy Inspire Veterinary Partners, Inc.. Stock? IVPR Key Strengths
- Modest revenue base of $12.2M provides foundation to build from
- Total assets of $24M exceed liabilities by $4.2M in book value
- Operating in agricultural services sector with structural demand
- Revenue has been relatively stable year over year, indicating the business still has an operating demand base
- Stockholders' equity remains positive at $4.17M despite heavy losses
- Capital expenditure requirements appear modest, which could help if operating performance improves
IVPR Stock Risks: Inspire Veterinary Partners, Inc.. Investment Risks
- Negative operating cash flow of -$3.6M with -29.7% FCF margin indicates cash burn from core operations
- Severe liquidity crisis: current ratio of 0.39x and only $576K cash cannot support $11.8M long-term debt obligations
- Operating losses of -$6.6M on $12.2M revenue (-53.8% margin) and net losses of -$8.0M (-65.2% margin) show fundamental business model failure
- Negative ROE of -191.3% and ROA of -33.3% destroying shareholder capital rapidly
- High leverage with 2.82x debt-to-equity ratio leaves minimal financial flexibility
- Profitability is extremely weak, with large operating and net losses consuming a substantial share of revenue
- Liquidity is strained, as shown by low cash balances and sub-1.0 current and quick ratios
- Leverage is high relative to equity, increasing refinancing, covenant, and dilution risk if losses persist
Key Metrics to Watch
- Operating cash flow trend - currently deeply negative, needs immediate reversal to positive
- Cash position and runway - critical given $576K cash versus burn rate
- Revenue stabilization - currently flat with -0.5% YoY decline despite losses
- Path to profitability - must demonstrate improvement in operating margins from -53.8%
- Operating margin and net loss trend
- Cash balance, operating cash flow, and current ratio
Inspire Veterinary Partners, Inc.. (IVPR) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
IVPR Profit Margin, ROE & Profitability Analysis
IVPR vs Services Sector: How Inspire Veterinary Partners, Inc.. Compares
How Inspire Veterinary Partners, Inc.. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Inspire Veterinary Partners, Inc.. Stock Overvalued? IVPR Valuation Analysis 2026
Based on fundamental analysis, Inspire Veterinary Partners, Inc.. shows some fundamental concerns relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Inspire Veterinary Partners, Inc.. Balance Sheet: IVPR Debt, Cash & Liquidity
IVPR Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Inspire Veterinary Partners, Inc..'s revenue has remained relatively flat over the 5-year period, with a 0% decline.
IVPR Revenue Growth, EPS Growth & YoY Performance
IVPR Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $4.0M | -$2.4M | N/A |
| Q2 2025 | $4.3M | -$2.4M | N/A |
| Q1 2025 | $3.6M | -$2.4M | N/A |
| Q3 2024 | $4.0M | -$1.2M | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Inspire Veterinary Partners, Inc.. Dividends, Buybacks & Capital Allocation
IVPR SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Inspire Veterinary Partners, Inc.. (CIK: 0001939365)
📋 Recent SEC Filings
❓ Frequently Asked Questions about IVPR
What is the AI rating for IVPR?
Inspire Veterinary Partners, Inc.. (IVPR) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 92% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are IVPR's key strengths?
Claude: Modest revenue base of $12.2M provides foundation to build from. Total assets of $24M exceed liabilities by $4.2M in book value. ChatGPT: Revenue has been relatively stable year over year, indicating the business still has an operating demand base. Stockholders' equity remains positive at $4.17M despite heavy losses.
What are the risks of investing in IVPR?
Claude: Negative operating cash flow of -$3.6M with -29.7% FCF margin indicates cash burn from core operations. Severe liquidity crisis: current ratio of 0.39x and only $576K cash cannot support $11.8M long-term debt obligations. ChatGPT: Profitability is extremely weak, with large operating and net losses consuming a substantial share of revenue. Liquidity is strained, as shown by low cash balances and sub-1.0 current and quick ratios.
What is IVPR's revenue and growth?
Inspire Veterinary Partners, Inc.. reported revenue of $12.2M.
Does IVPR pay dividends?
Inspire Veterinary Partners, Inc.. does not currently pay dividends.
Where can I find IVPR SEC filings?
Official SEC filings for Inspire Veterinary Partners, Inc.. (CIK: 0001939365) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is IVPR's EPS?
Inspire Veterinary Partners, Inc.. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is IVPR a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Inspire Veterinary Partners, Inc.. has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is IVPR stock overvalued or undervalued?
Valuation metrics for IVPR: ROE of -191.3% (sector avg: 16%), net margin of -65.2% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy IVPR stock in 2026?
Our dual AI analysis gives Inspire Veterinary Partners, Inc.. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is IVPR's free cash flow?
Inspire Veterinary Partners, Inc..'s operating cash flow is $-3.6M, with capital expenditures of $76.3K. FCF margin is -29.7%.
How does IVPR compare to other Services stocks?
Vs Services sector averages: Net margin -65.2% (avg: 10%), ROE -191.3% (avg: 16%), current ratio 0.39 (avg: 1.5).
Is Inspire Veterinary Partners, Inc.. carrying too much debt?
IVPR has a debt-to-equity ratio of 2.82x, which is above the Services sector average of 0.7x. Combined with a current ratio below 1, this warrants careful monitoring of the balance sheet.